โรคหลอดเลือดขอด โรงงาน, ซื้อคุณภาพดี โรคหลอดเลือดขอด ผลิตภัณฑ์ จากจีน

1-[2-ฟลอโร-6- ((trifluoromethyl) benzyl]-5-ยอโด-6-เมธีลไพริมิดีน-2,4 ((1H,3H) -ไดโอเน่ (1150560-54-5)

1-[2-fluoro-6-(trifluoromethyl)benzyl]-5-iodo-6-methylpyrimidine-2,4(1H,3H)-dione is an intermediate of Elagolix Sodium. Product Name: 1-[2-fluoro-6-(trifluoromethyl)benzyl]-5-iodo-6-methylpyrimidine-2,4(1H,3H)-dione CAS No.: 1150560-54-5 Assay: 98% End Use: Elagolix Sodium Molecular Formula: C13H9F4IN2O2 Molecular Weight: 428.12 Shelf Life: 2 Years Package: 25kg/drum

5-บรอม-1- ((2-ฟลอโร-6-ไตรฟลอโรเมธิล-เบนซิล) -6-เมธิล-1H-ไพริมิดีน-2,4-ไดโอเน่ (830346-48-0)

5-Bromo-1-(2-fluoro-6-trifluoromethyl-benzyl)-6-methyl-1H-pyrimidine-2,4-dione is an intermediate of Elagolix Sodium. Product Name: 5-Bromo-1-(2-fluoro-6-trifluoromethyl-benzyl)-6-methyl-1H-pyrimidine-2,4-dione CAS No.: 830346-48-0 Assay: 98% End Use: Elagolix Sodium Molecular Formula: C13H9F4BrN2O2 Molecular Weight: 381.12 Shelf Life: 2 Years Package: 25kg/drum

5- ((2-ฟลูโร-3-เมโตคซิเฟนิล)-1-[[2-ฟลูโร-6-(ไตรฟลูโรเมธีล)เฟนิล]เมธีล]-6-เมธีล-2,4 ((1H,3H) -ไพริมิดีน (1150560-59-0)

5-(2-Fluoro-3-methoxyphenyl)-1-[[2-fluoro-6-(trifluoromethyl)phenyl]methyl]-6-methyl-2,4(1H,3H)-pyrimidinedione is an intermediate of Elagolix Sodium. Product Name: 5-(2-Fluoro-3-methoxyphenyl)-1-[[2-fluoro-6-(trifluoromethyl)phenyl]methyl]-6-methyl-2,4(1H,3H)-pyrimidin CAS No.: 1150560-59-0 Assay: 98% End Use: Elagolix Sodium Molecular Formula: C20H15F5N2O3 Molecular Weight: 426.34 Shelf Life: 2 Years Package: 25kg/drum

กรดเบนเซนเอเซติก 4-ฟลอโร-อัลฟา- ((1-เมธีเลธิล) - (.อัลฟา.เอส) - (830346-47-9)

Benzeneacetic acid, 4-fluoro-.alpha.-(1-methylethyl)-, (.alpha.S)- is a key intermediate of Elagolix Sodium. Product Name: Benzeneacetic acid, 4-fluoro-.alpha.-(1-methylethyl)-, (.alpha.S)- CAS No.: 830346-47-9 Assay: 98% End Use: Elagolix Sodium Molecular Formula: C13H10F4N2O2 Molecular Weight: 302.22 Shelf Life: 2 Years Package: 25kg/drum

Elagolix โซเดียม (832720-36-2)

Elagolix sodium (ABT-620) is a small molecule, orally active gonadotropin-releasing hormone (GnRH) receptor antagonist. It has the ability to suppress estradiol (E2) concentrations in a dose-dependent manner. Elagolix is the first orally available GnRH antagonist, and as such may provide patients with relief from the painful symptoms of endometriosis while offering advantages over currently available injectable peptide-based treatments. The estimated patient population is

2-ฟลูโร-3-เมโตคซิเฟนิลโบรอนิกแอซิด (352303-67-4)

2-fluoro-3-methoxyphenylboronic acid is an intermediate of Elagolix Sodium. Product Name: 2-fluoro-3-methoxyphenylboronic acid CAS No.: 352303-67-4 Assay: 98% End Use: Elagolix Sodium Molecular Formula: C7H8BFO3 Molecular Weight: 169.95 Shelf Life: 2 Years Package: 25kg/drum